Analysis of recurrence and survival rates in grade 3 endometrioid endometrial carcinoma

about

Analysis of recurrence and survival rates in grade 3 endometrioid endometrial carcinoma

Item

http://www.wikidata.org/entity/Q37288075

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 28 July 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Analysis of recurrence and survival rates in grade 3 endometrioid endometrial carcinoma

@en

Analysis of recurrence and survival rates in grade 3 endometrioid endometrial carcinoma.

@nl

type

Item

label

Analysis of recurrence and survival rates in grade 3 endometrioid endometrial carcinoma

@en

Analysis of recurrence and survival rates in grade 3 endometrioid endometrial carcinoma.

@nl

prefLabel

Analysis of recurrence and survival rates in grade 3 endometrioid endometrial carcinoma

@en

Analysis of recurrence and survival rates in grade 3 endometrioid endometrial carcinoma.

@nl

P1476

Analysis of recurrence and survival rates in grade 3 endometrioid endometrial carcinoma

@en

P2093

Chao Wang

http://www.w3.org/2001/XMLSchema#string

Jieyu Wang

http://www.w3.org/2001/XMLSchema#string

Keqin Hua

http://www.w3.org/2001/XMLSchema#string

Nan Jia

http://www.w3.org/2001/XMLSchema#string

Qing Li

http://www.w3.org/2001/XMLSchema#string

Weiwei Feng

http://www.w3.org/2001/XMLSchema#string

Xiang Tao

http://www.w3.org/2001/XMLSchema#string

P2860

Adjuvant chemotherapy for advanced endometrial cancer

Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma.

Outcome of Endometrial Cancer Stage IIIA with Adnexa or Serosal Involvement Only.

Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial.

Oestrogen receptor beta expression and depth of myometrial invasion in human endometrial cancer.

A comparison of uterine papillary serous, clear cell carcinomas, and grade 3 endometrioid corpus cancers using 2009 FIGO staging system.

Overall survival and disease-free survival in endometrial cancer: prognostic factors in 276 patients.

Comparison of survival outcomes between patients with malignant mixed mullerian tumors and high-grade endometrioid, clear cell, and papillary serous endometrial cancers.

Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer.

Management of endometrial cancer in Asia: consensus statement from the Asian Oncology Summit 2009.

P304

2860-2867

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2016.4918

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27698871

http://www.w3.org/2001/XMLSchema#string

P932

5038389

http://www.w3.org/2001/XMLSchema#string